Immunological mechanisms in pathogenesis of coronary atherosclerosis

Terapevticheskii Arkhiv

Volumn 77, Issue 9, 2005, Pages 24-28

  Mazurov, V I ^a   Stolov, S V ^a   Zaraysky, M I ^a  

^a NONE

Author keywords

Coronary atherosclerosis; Cytokines; Interleukin; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; MEMBRANE ANTIGEN; MESSENGER RNA;

ANGINA PECTORIS; AORTA; ARTICLE; BLOOD; CHEMISTRY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GENETICS; HEART INFARCTION; HUMAN; IMMUNOLOGY; LYMPHOCYTE; MALE; METABOLISM; RADIAL ARTERY; UPREGULATION;

ANGINA PECTORIS; ANTIGENS, SURFACE; AORTA; CORONARY ARTERIOSCLEROSIS; CYTOKINES; FEMALE; HUMANS; LYMPHOCYTES; MALE; MYOCARDIAL INFARCTION; RADIAL ARTERY; RNA, MESSENGER; UP-REGULATION;

EID: 27644562198     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Demuth K., Myara I., Moatti N. Biology of the endothelial cell and atherogenesis. (Review). Ann. Biol. Clin. 1995; 53 (4): 171-191.
2. Ross R. Atherosclerosis is an inflammatory disease. N. Engl. J. Med. 1999; 340: 115-121.
3. Craig W. Y. Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology. (Review). J. Clin. Lab. Anal. 1995; 9 (1): 70-74.
4. Danesh J., Collins R., Appleby P. et al. Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. J. A. M. A. 1998; 279: 1477-1482.
5. Parissis J., Venetsanou K., Ziras N. Abnormal cytokine expression during the course of acute myocardial infarction. Eur. Heart J. 1998; 19 (suppl.): 508.
6. Shoenfeld Y., Sherer Y., George J., Harats D. Autoantibodies associated with atherosclerosis. Ann. Med. 2000; 32 (suppl. 1): 37-40.
7. Hansson G. K. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2001; 21: 1876-1890.
8. Watanabe T., Shimokama T., Haraoka S., Kishikawa H. T lymphocytes in atherosclerotic lesions. Ann. N. Y. Acad. Sci. 1995; 748: 40-55.
9. van der Wal A. C., Becker A. E. Immune and inflammatory responses in human atherosclerotic plaque // Schultheiss H., Schwimrnbeck P., eds. The role of immune mechanisms in cardiovascular disease. Berlin; 1997. 205-213.
10. Szekanecz Z., Shah M. R., Pearce W. H. Human atherosclerotic abdominal aortic aneurisms produce IL-6 and IFN-gamma but not IL-2 and IL-4: possible role for IL-6 and IFN-gamma in vascular inflammation. Agents Actions 1994; 42 (3-4): 159-162.
11. Tashiro H., Shimokawa H., Yamamoto K., Momohara M. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron. Artery Dis. 1997; 8 (3-4): 143-147.
12. Frostegard J., Ulfgren A. K., Nyberg P. et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999; 145: 33-43.
13. Mallat Z., Besnard S., Duriez M., Deleuze V. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 1999; 85: e17-e24.
14. Lijnen P. J., Petrov V. V., Fagard R. H. Induction of cardiac fibrosis by transforming growth factor-beta (1). Mol. Genet. Metab. 2000; 71 (1-2): 418-435.
15. Danesh J., Collins R., Appleby P., Peto R. Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. J. A. M. A. 1998; 279: 1477-1482.
16. Becker A. E., de Boer O. J., van der Wal A. C. The role of inflammation and infection in coronary artery disease. Annu. Rev. Med. 2001; 52: 289-297.
17. Anderson J. L., Carlquist J. F., Muhlestein J. B. et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J. Am. Coll. Cardiol. 1998; 32 (1): 35-41.